⚡Tesamorelin & Ipamorelin blended together are known as TESARAK⚡

“Two Peptides. One Destiny. Unlimited Power.”

⸻

📖 Origin Story

In the hidden vaults of cellular alchemy, two forces were never meant to meet. Tesamorelin, the ancient awakener of growth and renewal… and Ipamorelin, the silent sentinel of controlled release and balance.

Alone, they walked separate paths. But when combined in a single matrix, a rift opened — and from that union rose a new being: Te⚡araK!

A formulation forged not by chance, but by design. Half growth, half harmony — together more powerful than either could ever be.

⸻

⚡ Synergistic Benefits

 • Anabolic Ascension — accelerates cellular regeneration, muscle repair, and vitality.

 • Metabolic Equilibrium — stabilizes energy release for clean, steady power.

 • ChronoShield — slows the march of time at the cellular level, preserving youth.

 • Synergy Strike — when both forces unite, the effect multiplies — energy, recovery, and resilience at once.

⸻

🌌 The Legend

Whispered in labs, revered in research, and now unleashed — Tesarak is more than a formula. It is the symbol of a new frontier: where two become one, and biology becomes legend.

🔬 Mechanistic Synergy

 • Tesamorelin (GHRH analog):

• Mimics endogenous Growth Hormone–Releasing Hormone (GHRH).

• Stimulates the pituitary to release GH in a natural pulsatile pattern.

• Strongly enhances IGF-1 production in the liver.

 • Ipamorelin (Ghrelin mimetic / GHRP):

• Mimics ghrelin, binding to the ghrelin receptor (GHS-R1a).

• Triggers GH release through a different signaling pathway (not GHRH).

• Selective – does not significantly raise cortisol or prolactin (unlike older GHRPs).

✅ Together: They activate two separate receptor systems (GHRH receptor + Ghrelin receptor) that converge on the pituitary, leading to greater GH output than either alone while preserving physiologic pulsatility.

⸻

💡 Key Benefits of the Combination

1. Amplified GH Release

 • Tesamorelin “primes” somatotroph cells, while Ipamorelin “triggers” release.

 • This dual action can lead to higher amplitude GH pulses than either peptide by itself.

2. Improved IGF-1 Response

 • Tesamorelin is especially strong at raising IGF-1.

 • Ipamorelin boosts GH release in synergy, so IGF-1 output is often more sustained and reliable.

3. Balanced Physiologic Profile

 • Tesamorelin promotes natural rhythm.

 • Ipamorelin adds potency without spiking cortisol/prolactin.

 • Combination may mimic a youthful endocrine state more closely.

4. Potential Clinical/Research Advantages

 • Lipolysis & Body Composition: Tesamorelin already reduces visceral fat (FDA-approved for HIV lipodystrophy). Ipamorelin amplifies this effect via GH synergy.

 • Muscle Growth & Repair: GH/IGF-1 axis support for lean mass and tissue regeneration.

 • Neurocognitive & Anti-Aging Research: GH + IGF-1 linked to neurogenesis, memory support, and mitochondrial protection.

 • Metabolic Health: Potential improvements in insulin sensitivity, lipid profiles, and energy metabolism.

⸻

⚖️ Why in One Vial?

 • Stable Ratios: Ensures consistent dosing balance between Tesamorelin and Ipamorelin.

 • Synergy by Design: Both delivered simultaneously to maximize receptor crosstalk and GH release.

👉 In short: Tesamorelin “sets the stage,” Ipamorelin “pulls the trigger.” 🔫Together they create a stronger, more physiologic, and potentially more effective GH secretagogue profile than either peptide alone.

Te⚡araK TES/IPA 5/5 Protocol

Compound: Tesamorelin 5 mg + Ipamorelin 5 mg

Reconstitution Volume: 3 mL bacteriostatic water

⸻

⚗️ Final Concentration

 • Total: 10 mg / 3 mL = 3.33 mg/mL

 • Each peptide (equal ratio):

• Tesamorelin = 1.67 mg/mL

• Ipamorelin = 1.67 mg/mL

💡 Every 0.1 mL = 0.167 mg Tesamorelin + 0.167 mg Ipamorelin

⸻

💉 Dosing Protocol (Typical Research Range)

Volume

Tesamorelin Dose

Ipamorelin Dose

Notes

0.1 mL

0.167 mg

0.167 mg

Micro-dose, priming

0.2 mL

0.33 mg

0.33 mg

Light daily dose

0.3 mL

0.5 mg

0.5 mg

Common baseline dose

0.6 mL

1.0 mg

1.0 mg

High peak GH release

⏰ Timing Options

 • AM (fasted, pre-meal): 0.2–0.3 mL (≈0.33–0.5 mg each)

 • Optional PM (pre-bed): 0.2–0.3 mL (≈0.33–0.5 mg each)

 • Avoid carbs/fats 30–45 min post-injection for maximal GH response.

⸻

🔄 Cycling Recommendations

 • Standard: 5 days on / 2 days off

 • Cycle Length: 3–6 months, then 2–4 week washout

Te⚡araK TESA/IPA 10/3 Protocol

Vial Contents: Tesamorelin 10 mg + Ipamorelin 3 mg

Reconstitution Volume: 3 mL bacteriostatic water

⸻

⚗️ Final Concentration

 • Tesamorelin: 10 mg ÷ 3 mL = 3.33 mg/mL

 • Ipamorelin: 3 mg ÷ 3 mL = 1.0 mg/mL

 • Total concentration per mL: 4.33 mg/mL (combined)

👉 Every 0.1 mL = 0.333 mg Tesamorelin + 0.1 mg Ipamorelin

⸻

💉 Dosing Protocol (Research-Oriented)

Volume (mL)

Tesamorelin Dose

Ipamorelin Dose

Notes

0.1 mL

0.33 mg

0.10 mg

Micro-dose, priming

0.2 mL

0.67 mg

0.20 mg

Light/moderate dose

0.3 mL

1.0 mg

0.30 mg

Balanced research dose

0.6 mL

2.0 mg

0.60 mg

Higher-end pulse

⏰ Timing Suggestions

 • AM (fasted): 0.2–0.3 mL (≈0.67–1.0 mg Tesamorelin + 0.20–0.30 mg Ipamorelin)

 • Optional PM (bedtime): 0.1–0.2 mL (≈0.33–0.67 mg Tesamorelin + 0.10–0.20 mg Ipamorelin)

 • Avoid carbs/fats for 30–45 min after injection to optimize GH response.

⸻

🔄 Cycling Recommendations

 • 5 days on / 2 days off to maintain receptor sensitivity.

 • 3–6 months on, then take 2–4 weeks off.

⸻

🧠 Notes on Ratio (10:3 Tesa:Ipa)

 • This ratio favors Tesamorelin’s GHRH receptor stimulation → strong IGF-1 boost.

 • Ipamorelin is present at a lower but synergistic amount → ensures receptor crosstalk without overloading ghrelin pathways.

 • Practical: this setup is Tesamorelin-dominant, good for body composition, visceral fat reduction, and IGF-1 elevation, with Ipamorelin enhancing GH pulse amplitude.

⸻

✅ Summary: With this vial, 0.2–0.3 mL per injection delivers a research-effective, physiologic dose of both peptides in synergy.